anpac_logo_full color_stacked.png
AnPac Bio Announces Appointment of New Chief Financial Officer
02 juin 2020 17h00 HE | Anpac Bio, USA
SAN JOSE, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
anpac_logo_full color_stacked.png
AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States
26 mai 2020 08h00 HE | Anpac Bio, USA
SAN JOSE, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
anpac_logo_full color_stacked.png
AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019
18 mai 2020 08h30 HE | Anpac Bio, USA
Continued annual revenue growthNumber of commercial CDA (cancer differentiation analysis)-based tests increased 26.0% year-on-yearContinued to gain customers and increase the acceptance of our cancer...
anpac_logo_full color_stacked.png
AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States
11 mai 2020 06h46 HE | Anpac Bio, USA
SAN JOSE, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Co-Diagnostics (NASDAQ:CODX) Part of Silicon Slopes Initiative Inking “Big Dollar Contracts” for Coronavirus Testing
28 avr. 2020 12h25 HE | BDA International
New York City, April 28, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a Utah biotech with a unique, patented molecular diagnostic testing platform, recently announced...
Exagen_Full_CMYK_Print.jpg
Exagen to Announce First Quarter Financial Results on May 11, 2020
27 avr. 2020 08h25 HE | Exagen Inc.
SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
2019_10_18 Sense Logo - 2 colour - RGB - transparent.png
Sense Appoints John Bishop to its Board of Directors
21 avr. 2020 02h00 HE | Sense Biodetection
Former Cepheid CEO joins as company launches an accelerated program for the world’s first instrument-free molecular test for COVID-19 CAMBRIDGE and OXFORD, UNITED KINGDOM, April 21, 2020 (GLOBE...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Achieves Medical Importer Status with US FDA
15 avr. 2020 08h38 HE | Todos Medical Ltd.
REHOVOT, Israel, SINGAPORE and NEW YORK, NY, April 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF), a commercial in vitro diagnostics company focused on the...
PARALLAX LOGO.jpg
Parallax Health Sciences Announces Increased Customer Acquisition in Both Management and Diagnostics Divisions
09 avr. 2020 10h10 HE | Parallax Health Sciences, Inc.
Company Receives Over $10 million of Telehealth and Medical Supply Contracts from Coast to Coast  NEW YORK, NY, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Provides Corporate Update
09 avr. 2020 09h03 HE | Todos Medical Ltd.
 Corona Diagnostics JV adds COVID-19 EUA-submitted point-of-care antibody test kit suppliers Ongoing pre-commercial clinical trial for TMB-1 and TMB-2 progressing despite COVID-19 Full acquisition of...